Metraipolis › archive › dc_cd2d3ad3626b

Yangyin Fuzheng Jiedu prescription as an adjunct to minimally invasive treatment in early-stage hepatocellular carcinoma: a randomized controlled trial — Europe PMC PMID:42518346

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42518346
DOI
10.3389/fphar.2026.1780139
License (as archived)
solo-consultazione
Archived
2026-10-23T15:10:42.983Z
SHA-256 of the archived text
8536b5b97712a00ecfd957c649bc3f8882762864935598e715c09ba0503a070e
Stable URL of this page
https://metraipolis.com/documento/dc_cd2d3ad3626b

How to cite

Yangyin Fuzheng Jiedu prescription as an adjunct to minimally invasive treatment in early-stage hepatocellular carcinoma: a randomized controlled trial — Europe PMC PMID:42518346 — Europe PMC (en), https://europepmc.org/article/MED/42518346 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd2d3ad3626b (Metraipolis archive dc_cd2d3ad3626b, sha256 8536b5b97712a00ecfd957c649bc3f8882762864935598e715c09ba0503a070e)
BibTeX
@misc{dccd2d3ad3626b,
  title = {Yangyin Fuzheng Jiedu prescription as an adjunct to minimally invasive treatment in early-stage hepatocellular carcinoma: a randomized controlled trial — Europe PMC PMID:42518346},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42518346},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd2d3ad3626b; sha256 8536b5b97712a00ecfd957c649bc3f8882762864935598e715c09ba0503a070e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42518346. Agents can read the archived copy with the MCP tool read_document.